(Q45364835)

13 December 2017

Epstein-Barr virus and multiple sclerosis: interaction with HLA. (English)

1 reference

13 December 2017

0 references

0 references

8

1 reference

13 December 2017

M Lindén

3

0 references

Ingrid Kockum

object named as

I Kockum

7

0 references

Tommy Olsson

9

object named as

T Olsson

1 reference

13 December 2017

E Sundqvist

1

1 reference

13 December 2017

P Sundström

2

1 reference

13 December 2017

A K Hedström

4

1 reference

13 December 2017

F Aloisi

5

1 reference

13 December 2017

J Hillert

6

1 reference

13 December 2017

21 July 2011

1 reference

13 December 2017

1 reference

13 December 2017

13

1 reference

13 December 2017

1

1 reference

13 December 2017

14-20

1 reference

https://scigraph.springernature.com/pub.10.1038/gene.2011.42

13 December 2017

0 references

cites work

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Ubiquitous pathogens: links between infection and autoimmunity in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Epstein-barr virus infection and multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

A molecular trio in relapse and remission in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

21 January 2018

Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Multiple sclerosis and the major histocompatibility complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Calculating measures of biological interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

Confidence interval estimation of interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

7 January 2021

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

7 January 2021

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.42

7 January 2021

Identifiers

DOI

10.1038/GENE.2011.42

1 reference

Dimensions Publication ID

13 December 2017

0 references

1 reference